Burrill & Company

Investor type Private Equity Firm
Founders G. Steven Burrill


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 90
Average round size
The average size of a deal this fund participated in
Portfolio companies 57
Rounds per year 3.21
Lead investments 10
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 25
Key employees 5
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Medical Device

In 1994 was created Burrill & Company, which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

Comparing to the other companies, this Burrill & Company performs on 3 percentage points less the average number of lead investments. The top activity for fund was in 2004. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2014. When the investment is from Burrill & Company the average startup value is 50-100 millions dollars.

This organization was formed by G. Steven Burrill. We also calculated 5 valuable employees in our database.

The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Medical, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Catalyst Biosciences, diaDexus, Light Sciences Oncology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Burrill & Company, startups are often financed by Khosla Ventures, DSM Venturing, Prolog Ventures. The meaningful sponsors for the fund in investment in the same round are Prolog Ventures, Great Spirit Ventures, Novo Holdings. In the next rounds fund is usually obtained by Novo Holdings, Morgenthaler Ventures, Prolog Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Burrill & Company:
Typical Co-investors
Burrill & Company is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Burrill & Company:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Neos Therapeutics

Life Science
$20M19 Feb 2015 Grand Prairie, Texas, United States

Nora Therapeutics

Health Care
Medical Device
$18M17 Apr 2014 Palo Alto, California, United States

Neos Therapeutics

Life Science
$15M04 Mar 2014 Grand Prairie, Texas, United States


Developer APIs
Health Care
Search Engine
$2M22 Oct 2013 San Francisco, California, United States

Medical Device
$48M29 May 2013 Dubai, United Arab Emirates

Catalyst Biosciences

Health Care
Life Science
Medical Device
$5M01 Apr 2013 South San Francisco, California, United States

Odyssey Thera

Health Care
$2M14 Feb 2013 San Ramon, California, United States

MabVax Therapeutics

$5M20 Nov 2012 San Diego, California, United States

Cobalt Technologies

Industrial Chemicals
Specialty Chemicals
$5M01 Oct 2012 Mountain View, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Burrill & Company?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: